Significant decrease of saturation index in erythrocytes membrane from subjects with non-alcoholic fatty liver disease (NAFLD)

The lipidomic profiling of erythrocyte membranes is expected to provide a peculiar scenario at molecular level of metabolic and nutritional pathways which may influence the lipid balance and the adaptation and homeostasis of the organism. Considering that lipid accumulation in the cell is important...

Full description

Saved in:
Bibliographic Details
Published inLipids in health and disease Vol. 16; no. 1; p. 160
Main Authors Notarnicola, Maria, Caruso, Maria Gabriella, Tutino, Valeria, Bonfiglio, Caterina, Cozzolongo, Raffaele, Giannuzzi, Vito, De Nunzio, Valentina, De Leonardis, Giampiero, Abbrescia, Daniela I., Franco, Isabella, Intini, Vincenza, Mirizzi, Antonella, Osella, Alberto R.
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 23.08.2017
BioMed Central
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The lipidomic profiling of erythrocyte membranes is expected to provide a peculiar scenario at molecular level of metabolic and nutritional pathways which may influence the lipid balance and the adaptation and homeostasis of the organism. Considering that lipid accumulation in the cell is important in promoting tissue inflammation, the purpose of this study is to analyze the fatty acid profile in red blood cell membranes of patients with Non-Alcoholic Fatty Liver Disease (NAFLD), in order to identify and validate membrane profiles possibly associated with the degree of hepatic damage. This work presents data obtained at baseline from 101 subjects that participated to a nutritional trial (registration number: NCT02347696) enrolling consecutive subjects with NAFLD. Diagnosis of liver steatosis was performed by using vibration-controlled elastography implemented on FibroScan. Fatty acids, extracted from phospholipids of erythrocyte membranes, were quantified by gas chromatography method. The subjects with severe NAFLD showed a significant decrease of the ratio of stearic acid to oleic acid (saturation index, SI) compared to controls, 1.281 ± 0.31 vs 1.5 ± 0.29, respectively. Low levels of SI in red blood cell membranes, inversely associated with degree of liver damage, suggest that an impairment of circulating cell membrane structure can reflect modifications that take place in the liver. Subjects with severe NAFLDalso showed higher levels of elongase 5 enzymatic activity, evaluated as vaccenic acid to palmitoleic acid ratio. Starting from these evidences, our findings show the importance of lipidomic approach in the diagnosis and the staging of NAFLD.
AbstractList The lipidomic profiling of erythrocyte membranes is expected to provide a peculiar scenario at molecular level of metabolic and nutritional pathways which may influence the lipid balance and the adaptation and homeostasis of the organism. Considering that lipid accumulation in the cell is important in promoting tissue inflammation, the purpose of this study is to analyze the fatty acid profile in red blood cell membranes of patients with Non-Alcoholic Fatty Liver Disease (NAFLD), in order to identify and validate membrane profiles possibly associated with the degree of hepatic damage. This work presents data obtained at baseline from 101 subjects that participated to a nutritional trial (registration number: NCT02347696) enrolling consecutive subjects with NAFLD. Diagnosis of liver steatosis was performed by using vibration-controlled elastography implemented on FibroScan. Fatty acids, extracted from phospholipids of erythrocyte membranes, were quantified by gas chromatography method. The subjects with severe NAFLD showed a significant decrease of the ratio of stearic acid to oleic acid (saturation index, SI) compared to controls, 1.281 [+ or -] 0.31 vs 1.5 [+ or -] 0.29, respectively. Low levels of SI in red blood cell membranes, inversely associated with degree of liver damage, suggest that an impairment of circulating cell membrane structure can reflect modifications that take place in the liver. Subjects with severe NAFLDalso showed higher levels of elongase 5 enzymatic activity, evaluated as vaccenic acid to palmitoleic acid ratio. Starting from these evidences, our findings show the importance of lipidomic approach in the diagnosis and the staging of NAFLD.
The lipidomic profiling of erythrocyte membranes is expected to provide a peculiar scenario at molecular level of metabolic and nutritional pathways which may influence the lipid balance and the adaptation and homeostasis of the organism. Considering that lipid accumulation in the cell is important in promoting tissue inflammation, the purpose of this study is to analyze the fatty acid profile in red blood cell membranes of patients with Non-Alcoholic Fatty Liver Disease (NAFLD), in order to identify and validate membrane profiles possibly associated with the degree of hepatic damage. This work presents data obtained at baseline from 101 subjects that participated to a nutritional trial (registration number: NCT02347696) enrolling consecutive subjects with NAFLD. Diagnosis of liver steatosis was performed by using vibration-controlled elastography implemented on FibroScan. Fatty acids, extracted from phospholipids of erythrocyte membranes, were quantified by gas chromatography method. The subjects with severe NAFLD showed a significant decrease of the ratio of stearic acid to oleic acid (saturation index, SI) compared to controls, 1.281 ± 0.31 vs 1.5 ± 0.29, respectively. Low levels of SI in red blood cell membranes, inversely associated with degree of liver damage, suggest that an impairment of circulating cell membrane structure can reflect modifications that take place in the liver. Subjects with severe NAFLDalso showed higher levels of elongase 5 enzymatic activity, evaluated as vaccenic acid to palmitoleic acid ratio. Starting from these evidences, our findings show the importance of lipidomic approach in the diagnosis and the staging of NAFLD.
The lipidomic profiling of erythrocyte membranes is expected to provide a peculiar scenario at molecular level of metabolic and nutritional pathways which may influence the lipid balance and the adaptation and homeostasis of the organism. Considering that lipid accumulation in the cell is important in promoting tissue inflammation, the purpose of this study is to analyze the fatty acid profile in red blood cell membranes of patients with Non-Alcoholic Fatty Liver Disease (NAFLD), in order to identify and validate membrane profiles possibly associated with the degree of hepatic damage.BACKGROUNDThe lipidomic profiling of erythrocyte membranes is expected to provide a peculiar scenario at molecular level of metabolic and nutritional pathways which may influence the lipid balance and the adaptation and homeostasis of the organism. Considering that lipid accumulation in the cell is important in promoting tissue inflammation, the purpose of this study is to analyze the fatty acid profile in red blood cell membranes of patients with Non-Alcoholic Fatty Liver Disease (NAFLD), in order to identify and validate membrane profiles possibly associated with the degree of hepatic damage.This work presents data obtained at baseline from 101 subjects that participated to a nutritional trial (registration number: NCT02347696) enrolling consecutive subjects with NAFLD. Diagnosis of liver steatosis was performed by using vibration-controlled elastography implemented on FibroScan. Fatty acids, extracted from phospholipids of erythrocyte membranes, were quantified by gas chromatography method.METHODSThis work presents data obtained at baseline from 101 subjects that participated to a nutritional trial (registration number: NCT02347696) enrolling consecutive subjects with NAFLD. Diagnosis of liver steatosis was performed by using vibration-controlled elastography implemented on FibroScan. Fatty acids, extracted from phospholipids of erythrocyte membranes, were quantified by gas chromatography method.The subjects with severe NAFLD showed a significant decrease of the ratio of stearic acid to oleic acid (saturation index, SI) compared to controls, 1.281 ± 0.31 vs 1.5 ± 0.29, respectively. Low levels of SI in red blood cell membranes, inversely associated with degree of liver damage, suggest that an impairment of circulating cell membrane structure can reflect modifications that take place in the liver. Subjects with severe NAFLDalso showed higher levels of elongase 5 enzymatic activity, evaluated as vaccenic acid to palmitoleic acid ratio.RESULTSThe subjects with severe NAFLD showed a significant decrease of the ratio of stearic acid to oleic acid (saturation index, SI) compared to controls, 1.281 ± 0.31 vs 1.5 ± 0.29, respectively. Low levels of SI in red blood cell membranes, inversely associated with degree of liver damage, suggest that an impairment of circulating cell membrane structure can reflect modifications that take place in the liver. Subjects with severe NAFLDalso showed higher levels of elongase 5 enzymatic activity, evaluated as vaccenic acid to palmitoleic acid ratio.Starting from these evidences, our findings show the importance of lipidomic approach in the diagnosis and the staging of NAFLD.CONCLUSIONSStarting from these evidences, our findings show the importance of lipidomic approach in the diagnosis and the staging of NAFLD.
Background The lipidomic profiling of erythrocyte membranes is expected to provide a peculiar scenario at molecular level of metabolic and nutritional pathways which may influence the lipid balance and the adaptation and homeostasis of the organism. Considering that lipid accumulation in the cell is important in promoting tissue inflammation, the purpose of this study is to analyze the fatty acid profile in red blood cell membranes of patients with Non-Alcoholic Fatty Liver Disease (NAFLD), in order to identify and validate membrane profiles possibly associated with the degree of hepatic damage. Methods This work presents data obtained at baseline from 101 subjects that participated to a nutritional trial (registration number: NCT02347696) enrolling consecutive subjects with NAFLD. Diagnosis of liver steatosis was performed by using vibration-controlled elastography implemented on FibroScan. Fatty acids, extracted from phospholipids of erythrocyte membranes, were quantified by gas chromatography method. Results The subjects with severe NAFLD showed a significant decrease of the ratio of stearic acid to oleic acid (saturation index, SI) compared to controls, 1.281 [+ or -] 0.31 vs 1.5 [+ or -] 0.29, respectively. Low levels of SI in red blood cell membranes, inversely associated with degree of liver damage, suggest that an impairment of circulating cell membrane structure can reflect modifications that take place in the liver. Subjects with severe NAFLDalso showed higher levels of elongase 5 enzymatic activity, evaluated as vaccenic acid to palmitoleic acid ratio. Conclusions Starting from these evidences, our findings show the importance of lipidomic approach in the diagnosis and the staging of NAFLD. Keywords: Lipidomic analysis, Fatty acids profile, NAFLD, Erythrocyte membrane, Saturation index
ArticleNumber 160
Audience Academic
Author De Nunzio, Valentina
Abbrescia, Daniela I.
Osella, Alberto R.
Mirizzi, Antonella
De Leonardis, Giampiero
Tutino, Valeria
Giannuzzi, Vito
Cozzolongo, Raffaele
Franco, Isabella
Intini, Vincenza
Notarnicola, Maria
Caruso, Maria Gabriella
Bonfiglio, Caterina
Author_xml – sequence: 1
  givenname: Maria
  surname: Notarnicola
  fullname: Notarnicola, Maria
– sequence: 2
  givenname: Maria Gabriella
  surname: Caruso
  fullname: Caruso, Maria Gabriella
– sequence: 3
  givenname: Valeria
  surname: Tutino
  fullname: Tutino, Valeria
– sequence: 4
  givenname: Caterina
  surname: Bonfiglio
  fullname: Bonfiglio, Caterina
– sequence: 5
  givenname: Raffaele
  surname: Cozzolongo
  fullname: Cozzolongo, Raffaele
– sequence: 6
  givenname: Vito
  surname: Giannuzzi
  fullname: Giannuzzi, Vito
– sequence: 7
  givenname: Valentina
  surname: De Nunzio
  fullname: De Nunzio, Valentina
– sequence: 8
  givenname: Giampiero
  surname: De Leonardis
  fullname: De Leonardis, Giampiero
– sequence: 9
  givenname: Daniela I.
  surname: Abbrescia
  fullname: Abbrescia, Daniela I.
– sequence: 10
  givenname: Isabella
  surname: Franco
  fullname: Franco, Isabella
– sequence: 11
  givenname: Vincenza
  surname: Intini
  fullname: Intini, Vincenza
– sequence: 12
  givenname: Antonella
  surname: Mirizzi
  fullname: Mirizzi, Antonella
– sequence: 13
  givenname: Alberto R.
  surname: Osella
  fullname: Osella, Alberto R.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28830448$$D View this record in MEDLINE/PubMed
BookMark eNp1Us9vFCEYJabG_tA_wIsh8dIepvLNDMNwMdlUqyYbPdiDN8Iw3-zSzEAFpnUv_u1lu61pjQYCBN57fPDeIdlz3iEhr4GdArTNuwilrOuCgSgY52XBnpEDqEVTcIAfe4_W--QwxkvGSiaa5gXZL9u2YnXdHpDf3-3K2cEa7RLt0QTUEakfaNRpDjpZ76h1Pf7KI8WwSevgzSZhpBNOXdAO6RD8ROPcXaJJkd7YtKa5zkKPxq_9aA0ddEobOtprDLS38e6G46-L8-WHk5fk-aDHiK_u5yNycf7x4uxzsfz26cvZYlmYumlS0UrNhCgbUbG-7FCb3GU_dDhAxesOZC8ZFzVIaHkFshFSCi5r4CA1IlZH5P1O9mruJuwNuhT0qK6CnXTYKK-tenri7Fqt_LXivGmZlFng-F4g-J8zxqQmGw2OY_4AP0cFsgIBjWjLDH27g670iMq6wWdFs4WrRfaiFFBLllGn_0Dl1uNkTbZ5sHn_CeHN4yf8qf3BygwQO4AJPsaAgzI23RmYle2ogKltaNQuNCqHRm1Do7bS8BfzQfz_nFs5psTV
CitedBy_id crossref_primary_10_3390_nu12030693
crossref_primary_10_1111_hepr_13571
crossref_primary_10_1016_j_metabol_2022_155200
crossref_primary_10_3390_nu10091299
crossref_primary_10_1016_j_jacl_2020_08_007
crossref_primary_10_3390_ijms22083899
crossref_primary_10_33380_2305_2066_2021_10_4_1__206_214
crossref_primary_10_3390_ijms241512074
crossref_primary_10_47093_2218_7332_2024_15_2_48_60
crossref_primary_10_3390_nu12061652
crossref_primary_10_3390_nu12113446
crossref_primary_10_3892_etm_2020_8446
crossref_primary_10_3390_nu11112744
crossref_primary_10_1016_j_psj_2022_102352
crossref_primary_10_1093_ajcn_nqab263
crossref_primary_10_3390_ijms24021739
crossref_primary_10_3390_ijms25158285
crossref_primary_10_3390_jpm14030315
crossref_primary_10_21518_ms2024_397
crossref_primary_10_3390_metabo14010054
crossref_primary_10_3390_ijms19040962
crossref_primary_10_1371_journal_pone_0279274
crossref_primary_10_3390_jcm10204673
crossref_primary_10_1186_s12864_024_10270_w
Cites_doi 10.1016/0009-8981(81)90235-7
10.1016/j.plefa.2012.02.009
10.1194/jlr.M700600-JLR200
10.1002/(SICI)1097-0215(19991126)83:5<585::AID-IJC2>3.0.CO;2-Z
10.3945/ajcn.111.012054
10.1093/jnci/93.14.1088
10.1016/S1665-2681(19)31182-2
10.1136/bmj.291.6489.163
10.15288/jsa.1982.43.1157
10.1016/j.jhep.2004.02.013
10.1038/bjc.1987.223
10.1016/j.jhep.2014.01.017
10.1002/hep.21874
10.1016/j.jhep.2016.05.013
10.1007/BF02139217
10.1002/hep.21763
10.2174/1574887109666141216101630
10.1016/j.amjcard.2012.04.027
10.1056/NEJM197710272971714
ContentType Journal Article
Copyright COPYRIGHT 2017 BioMed Central Ltd.
The Author(s). 2017
Copyright_xml – notice: COPYRIGHT 2017 BioMed Central Ltd.
– notice: The Author(s). 2017
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1186/s12944-017-0552-0
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1476-511X
ExternalDocumentID PMC5568099
A511271490
28830448
10_1186_s12944_017_0552_0
Genre Journal Article
GeographicLocations Italy
GeographicLocations_xml – name: Italy
GrantInformation_xml – fundername: ;
  grantid: Project identification code n° 6/CE IRCCS “De Bellis”
GroupedDBID ---
0R~
29L
2WC
53G
5GY
5VS
7X7
88E
8FE
8FH
8FI
8FJ
A8Z
AAFWJ
AAHBH
AAJSJ
AASML
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BBNVY
BCNDV
BENPR
BFQNJ
BHPHI
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EJD
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
H13
HCIFZ
HH5
HMCUK
HYE
IAO
IGS
IHR
INH
INR
ITC
KQ8
LK8
M1P
M48
M7P
M~E
O5R
O5S
OK1
OVT
P2P
P6G
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
SV3
TR2
TUS
U2A
UKHRP
W2D
WOQ
WOW
XSB
-A0
3V.
ACRMQ
ADINQ
C24
CGR
CUY
CVF
ECM
EIF
FRP
NPM
PMFND
7X8
PPXIY
PQGLB
5PM
PJZUB
ID FETCH-LOGICAL-c466t-89a07726730d2beaceac9dfbef1354b19d9057419185319679975941519aeee3
IEDL.DBID M48
ISSN 1476-511X
IngestDate Thu Aug 21 14:11:26 EDT 2025
Fri Jul 11 16:47:35 EDT 2025
Tue Jun 17 21:49:27 EDT 2025
Tue Jun 10 20:08:35 EDT 2025
Wed Feb 19 02:43:05 EST 2025
Tue Jul 01 00:23:09 EDT 2025
Thu Apr 24 22:53:42 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Erythrocyte membrane
Fatty acids profile
NAFLD
Lipidomic analysis
Saturation index
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c466t-89a07726730d2beaceac9dfbef1354b19d9057419185319679975941519aeee3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12944-017-0552-0
PMID 28830448
PQID 1931716782
PQPubID 23479
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5568099
proquest_miscellaneous_1931716782
gale_infotracmisc_A511271490
gale_infotracacademiconefile_A511271490
pubmed_primary_28830448
crossref_citationtrail_10_1186_s12944_017_0552_0
crossref_primary_10_1186_s12944_017_0552_0
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-8-23
2017-Aug-23
20170823
PublicationDateYYYYMMDD 2017-08-23
PublicationDate_xml – month: 08
  year: 2017
  text: 2017-8-23
  day: 23
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Lipids in health and disease
PublicationTitleAlternate Lipids Health Dis
PublicationYear 2017
Publisher BioMed Central Ltd
BioMed Central
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
References V Pala (552_CR7) 2001; 93
M Pandey (552_CR8) 2003; 1
RA Cooper (552_CR2) 1977; 297
CB Wood (552_CR11) 1985; 11
JK Yee (552_CR22) 2008; 49
SH Caldwell (552_CR19) 2004; 40
G Serviddio (552_CR6) 2016; 9
V Chajes (552_CR12) 1999; 83
HA Skinner (552_CR16) 1982; 43
A Berzigotti (552_CR14) 2014; 9
J Folch (552_CR18) 1957; 226
K Apostolov (552_CR10) 1985; 50
R Block (552_CR23) 2012; 86
NA Habib (552_CR1) 1987; 56
SB Kelly (552_CR21) 1990; 33
G Targher (552_CR26) 2016; 65
P Almeda-Valdes (552_CR13) 2015; 14
G Coviello (552_CR9) 2014; 34
JHY Wu (552_CR25) 2011; 94
T Moilanen (552_CR17) 1981; 114
RA Persad (552_CR4) 1990; 65
A Berzigotti (552_CR15) 2014; 60
CB Wood (552_CR3) 1985; 291
N Matsuzawa (552_CR20) 2007; 46
P Puri (552_CR5) 2007; 46
L Djoussè (552_CR24) 2012; 110
10521790 - Int J Cancer. 1999 Nov 26;83(5):585-90
11459870 - J Natl Cancer Inst. 2001 Jul 18;93(14):1088-95
2242696 - Dis Colon Rectum. 1990 Dec;33(12):1026-30
15030972 - J Hepatol. 2004 Apr;40(4):578-84
22417701 - Prostaglandins Leukot Essent Fatty Acids. 2012 Apr;86(4-5):175-82
327326 - N Engl J Med. 1977 Aug 18;297(7):371-7
7182675 - J Stud Alcohol. 1982 Nov;43(11):1157-70
25514917 - Rev Recent Clin Trials. 2014;9(3):170-7
22579341 - Am J Cardiol. 2012 Aug 15;110(4):539-44
27212244 - J Hepatol. 2016 Sep;65(3):589-600
4007173 - Eur J Surg Oncol. 1985 Jun;11(2):167-9
17654743 - Hepatology. 2007 Oct;46(4):1081-90
3689663 - Br J Cancer. 1987 Oct;56(4):455-8
26019047 - Ann Hepatol. 2015 Jul-Aug;14(4):567-9
25202057 - Anticancer Res. 2014 Sep;34(9):4775-9
2337746 - Br J Urol. 1990 Mar;65(3):268-70
18599738 - J Lipid Res. 2008 Oct;49(10):2124-34
3926106 - Br Med J (Clin Res Ed). 1985 Jul 20;291(6489):163-5
13428781 - J Biol Chem. 1957 May;226(1):497-509
21697077 - Am J Clin Nutr. 2011 Aug;94(2):431-8
12793905 - World J Surg Oncol. 2003 May 7;1(1):5
17929294 - Hepatology. 2007 Nov;46(5):1392-403
27639112 - Redox Biol. 2016 Oct;9:296-305
7249369 - Clin Chim Acta. 1981 Jul 18;114(1):111-6
3859340 - Blut. 1985 Jun;50(6):349-54
24486330 - J Hepatol. 2014 May;60(5):910-2
References_xml – volume: 114
  start-page: 111
  year: 1981
  ident: 552_CR17
  publication-title: Clin Chim Acta
  doi: 10.1016/0009-8981(81)90235-7
– volume: 86
  start-page: 175
  year: 2012
  ident: 552_CR23
  publication-title: Prostagl Leuk Essen Fatty Acid
  doi: 10.1016/j.plefa.2012.02.009
– volume: 49
  start-page: 2124
  year: 2008
  ident: 552_CR22
  publication-title: J Lipid Res
  doi: 10.1194/jlr.M700600-JLR200
– volume: 11
  start-page: 167
  year: 1985
  ident: 552_CR11
  publication-title: Eur J Surg Oncol
– volume: 1
  start-page: 5
  year: 2003
  ident: 552_CR8
  publication-title: World JSurgOncol
– volume: 83
  start-page: 585
  year: 1999
  ident: 552_CR12
  publication-title: Int J Cancer
  doi: 10.1002/(SICI)1097-0215(19991126)83:5<585::AID-IJC2>3.0.CO;2-Z
– volume: 226
  start-page: 497
  year: 1957
  ident: 552_CR18
  publication-title: J BiolChem
– volume: 94
  start-page: 431
  year: 2011
  ident: 552_CR25
  publication-title: Am J Clin Nutr
  doi: 10.3945/ajcn.111.012054
– volume: 93
  start-page: 1088
  year: 2001
  ident: 552_CR7
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/93.14.1088
– volume: 65
  start-page: 268
  year: 1990
  ident: 552_CR4
  publication-title: Br JUrol
– volume: 50
  start-page: 349
  year: 1985
  ident: 552_CR10
  publication-title: Blutalkohol
– volume: 14
  start-page: 567
  year: 2015
  ident: 552_CR13
  publication-title: Annals of Hepatol
  doi: 10.1016/S1665-2681(19)31182-2
– volume: 291
  start-page: 163
  year: 1985
  ident: 552_CR3
  publication-title: Br Med J
  doi: 10.1136/bmj.291.6489.163
– volume: 43
  start-page: 1157
  year: 1982
  ident: 552_CR16
  publication-title: J Stud Alcohol
  doi: 10.15288/jsa.1982.43.1157
– volume: 40
  start-page: 578
  year: 2004
  ident: 552_CR19
  publication-title: JHepatol
  doi: 10.1016/j.jhep.2004.02.013
– volume: 56
  start-page: 455
  year: 1987
  ident: 552_CR1
  publication-title: Br J Cancer
  doi: 10.1038/bjc.1987.223
– volume: 60
  start-page: 910
  year: 2014
  ident: 552_CR15
  publication-title: JHepatol.
  doi: 10.1016/j.jhep.2014.01.017
– volume: 34
  start-page: 4775
  year: 2014
  ident: 552_CR9
  publication-title: Anticancer Res
– volume: 46
  start-page: 1392
  year: 2007
  ident: 552_CR20
  publication-title: Hepatology
  doi: 10.1002/hep.21874
– volume: 65
  start-page: 589
  year: 2016
  ident: 552_CR26
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2016.05.013
– volume: 33
  start-page: 1026
  year: 1990
  ident: 552_CR21
  publication-title: Dis Colon Rectum
  doi: 10.1007/BF02139217
– volume: 46
  start-page: 1081
  year: 2007
  ident: 552_CR5
  publication-title: Hepathology
  doi: 10.1002/hep.21763
– volume: 9
  start-page: 170
  year: 2014
  ident: 552_CR14
  publication-title: Rev Rec Clin Trials
  doi: 10.2174/1574887109666141216101630
– volume: 110
  start-page: 539
  year: 2012
  ident: 552_CR24
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2012.04.027
– volume: 9
  start-page: 296
  year: 2016
  ident: 552_CR6
  publication-title: RedBiol
– volume: 297
  start-page: 371
  year: 1977
  ident: 552_CR2
  publication-title: N Engl J Med
  doi: 10.1056/NEJM197710272971714
– reference: 18599738 - J Lipid Res. 2008 Oct;49(10):2124-34
– reference: 7182675 - J Stud Alcohol. 1982 Nov;43(11):1157-70
– reference: 17929294 - Hepatology. 2007 Nov;46(5):1392-403
– reference: 25202057 - Anticancer Res. 2014 Sep;34(9):4775-9
– reference: 27212244 - J Hepatol. 2016 Sep;65(3):589-600
– reference: 13428781 - J Biol Chem. 1957 May;226(1):497-509
– reference: 26019047 - Ann Hepatol. 2015 Jul-Aug;14(4):567-9
– reference: 12793905 - World J Surg Oncol. 2003 May 7;1(1):5
– reference: 2337746 - Br J Urol. 1990 Mar;65(3):268-70
– reference: 327326 - N Engl J Med. 1977 Aug 18;297(7):371-7
– reference: 15030972 - J Hepatol. 2004 Apr;40(4):578-84
– reference: 3926106 - Br Med J (Clin Res Ed). 1985 Jul 20;291(6489):163-5
– reference: 25514917 - Rev Recent Clin Trials. 2014;9(3):170-7
– reference: 2242696 - Dis Colon Rectum. 1990 Dec;33(12):1026-30
– reference: 22417701 - Prostaglandins Leukot Essent Fatty Acids. 2012 Apr;86(4-5):175-82
– reference: 10521790 - Int J Cancer. 1999 Nov 26;83(5):585-90
– reference: 21697077 - Am J Clin Nutr. 2011 Aug;94(2):431-8
– reference: 27639112 - Redox Biol. 2016 Oct;9:296-305
– reference: 11459870 - J Natl Cancer Inst. 2001 Jul 18;93(14):1088-95
– reference: 3859340 - Blut. 1985 Jun;50(6):349-54
– reference: 22579341 - Am J Cardiol. 2012 Aug 15;110(4):539-44
– reference: 17654743 - Hepatology. 2007 Oct;46(4):1081-90
– reference: 3689663 - Br J Cancer. 1987 Oct;56(4):455-8
– reference: 24486330 - J Hepatol. 2014 May;60(5):910-2
– reference: 7249369 - Clin Chim Acta. 1981 Jul 18;114(1):111-6
– reference: 4007173 - Eur J Surg Oncol. 1985 Jun;11(2):167-9
SSID ssj0020766
Score 2.25209
Snippet The lipidomic profiling of erythrocyte membranes is expected to provide a peculiar scenario at molecular level of metabolic and nutritional pathways which may...
Background The lipidomic profiling of erythrocyte membranes is expected to provide a peculiar scenario at molecular level of metabolic and nutritional pathways...
SourceID pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 160
SubjectTerms Adult
Analysis
Azotemia - blood
Body Mass Index
Cell membranes
Cholesterol, HDL - blood
Chromatography, Gas
Development and progression
Erythrocyte Membrane - metabolism
Fatty Acids - metabolism
Fatty liver
Female
Ferritins - blood
Humans
Insulin - blood
Liver - metabolism
Male
Middle Aged
Non-alcoholic Fatty Liver Disease - blood
Non-alcoholic Fatty Liver Disease - metabolism
Physiological aspects
Red blood cells
Triglycerides - blood
Title Significant decrease of saturation index in erythrocytes membrane from subjects with non-alcoholic fatty liver disease (NAFLD)
URI https://www.ncbi.nlm.nih.gov/pubmed/28830448
https://www.proquest.com/docview/1931716782
https://pubmed.ncbi.nlm.nih.gov/PMC5568099
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9NAEB_OOxBfRO_8qJ5lBfELommy2U0eRKJeOYot4t1B35ZNsquFNtUmBfPi3-7MJi2tHD4IJX3Y3bDsfP1mZzID8CwKYquF1V6ibeBxrQvUg-HAy4TluQ6KLHTR8_FEnF_x0TSaHsCmvVV3gNW1rh31k7pazd_8-tm8R4F_5wQ-Fm8rtFmccimk50dR4KEHf4SGSVJDgzHfBhUCdNlFF9i8dhkVBo5j9O-pGdCOlfpbV-8Yq_1Eyh3LNLwDtztIydKWB-7CgSmP4SQt0Z1eNOw5c0me7vb8GG6Ou1j6Cfy-mH0rKVEIz5YVDj1Whi0tq6jWpyMYc7UU8cnMqqGGCnmDyJQtzAJ97NIw-jaFVeuM7nIqRle6rFyWnm7b7s5yZnVdN2xOuR-sCwWxl5N0-PnTq3twOTy7_Hjudd0YvJwLUXtxon2E4gJVQhFkqK_xlxQ2M3YQRjwbJEWC2I-j_xc7uZZJIqME8cEg0caY8D4c4hbMQ2AGQUfGfWsRHXKTk88oTCA1MlMQGhn1wN8cvsq7SuXUMGOunMcSC9WSTiHpFJFO-T14vV3yoy3T8a_JL4iiipgK35vr7ksE3B0Vw1IpgVCJriPOPN2biaKX7w0_3fCEoiHKVyvNcl0phMVUhwjhVw8etDyy3deGx3og97hnO4Eqfu-PlLPvrvI3lYtDSP_ov1c-hluBY3hUj-EpHNartXmCqKrO-nBDTmUfjtJ0dDHC_w9nky9f--6Oou_k6A9ZESXX
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Significant+decrease+of+saturation+index+in+erythrocytes+membrane+from+subjects+with+non-alcoholic+fatty+liver+disease+%28NAFLD%29&rft.jtitle=Lipids+in+health+and+disease&rft.au=Notarnicola%2C+Maria&rft.au=Caruso%2C+Maria+Gabriella&rft.au=Tutino%2C+Valeria&rft.au=Bonfiglio%2C+Caterina&rft.date=2017-08-23&rft.pub=BioMed+Central&rft.eissn=1476-511X&rft.volume=16&rft_id=info:doi/10.1186%2Fs12944-017-0552-0&rft_id=info%3Apmid%2F28830448&rft.externalDocID=PMC5568099
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1476-511X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1476-511X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1476-511X&client=summon